FIELD: organic chemistry.
SUBSTANCE: present invention relates to a compound of formula (I)
where A is a group
in which 1 denotes a point of attachment to -NH- and 2 denotes a point of attachment to the phenyl ring. Values of radicals are given in the claim. Also disclosed is a method of producing compound (I), compound of formula (VIA) and use thereof, compound of formula (VIB), compound of formula (VIIB) and use thereof, pharmaceutical compositions which inhibit Mcl-1, use of the pharmaceutical composition, use of the compound of formula (I), (VIIA) or (VIIB), a combination inhibiting Mcl-1, using the combination, use of the compound of formula (I), (VIIA) or (VIIB).
EFFECT: disclosed are new compounds inhibiting Mcl-1 and possessing apoptotic properties, which enables their use for treating malignant growths and autoimmune diseases and immune system diseases.
36 cl, 22 ex, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
NOVEL AMINO ACID DERIVATIVES, A METHOD FOR PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | 2016 |
|
RU2747673C2 |
NOVEL AMMONIUM DERIVATIVES, A METHOD FOR PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | 2016 |
|
RU2743098C2 |
NOVEL HYDROXY ACID DERIVATIVES, A METHOD FOR PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | 2016 |
|
RU2745430C1 |
NEW BICYCLIC DERIVATIVES, METHOD FOR THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | 2016 |
|
RU2760554C1 |
NOVEL THIENO-PYRIMIDINE DERIVATIVES, METHOD FOR PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | 2014 |
|
RU2605403C2 |
COMBINATION OF AN MCL-1 INHIBITOR AND A STANDARD DRUG FOR THE TREATMENT OF HEMATOLOGICAL MALIGNANCIES, ITS USE AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT | 2018 |
|
RU2792057C2 |
COMBINATION OF MCL-1 INHIBITOR AND TAXANE COMPOUND, THEIR APPLICATIONS AND PHARMACEUTICAL COMPOSITIONS | 2018 |
|
RU2763544C2 |
COMBINATION OF MCL-1 INHIBITOR AND MIDOSTAURIN, ITS APPLICATIONS AND PHARMACEUTICAL COMPOSITIONS | 2019 |
|
RU2818453C2 |
COMBINATION OF BCL-2 INHIBITOR AND MCL-1 INHIBITOR, USE AND PHARMACEUTICAL COMPOSITIONS THEREOF | 2017 |
|
RU2746705C2 |
NEW INDOLIZINE COMPOUNDS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | 2013 |
|
RU2646223C2 |
Authors
Dates
2020-10-16—Published
2016-06-22—Filed